Patents by Inventor Ashani Weeraratna

Ashani Weeraratna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Classifying cancers
    Patent number: 7247426
    Abstract: The overexpression of certain marker genes including Wnt5a has been found useful in the identification of more aggressive forms of malignant melanoma. Therefore, the overexpression of these genes in tumor samples of malignant melanoma may be useful in the diagnosis, profiling, and treatment of patients suffering from this disease. Inhibitors of Wnt5a activity may be useful in the treatment of aggressive forms of malignant melanoma. Inhibition of Wnt5a activity may be effected by any method including anti-sense therapy, gene therapy, and pharmaceutical intervention.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: July 24, 2007
    Assignee: Agilent Technologies, Inc.
    Inventors: Zohar Yakhini, Michael Bittner, Jeff Trent, Amir Ben-Dor, Paul Meltzer, Yidong Chen, Ashani Weeraratna, Yuan Jiang, Nick Sampas, Edward Dougherty
  • Classifying cancers
    Publication number: 20030152923
    Abstract: The overexpression of certain marker genes including Wnt5a has been found useful in the identification of more aggressive forms of malignant melanoma. Therefore, the overexpression of these genes in tumor samples of malignant melanoma may be useful in the diagnosis, profiling, and treatment of patients suffering from this disease. Inhibitors of Wnt5a activity may be useful in the treatment of aggressive forms of malignant melanoma. Inhibition of Wnt5a activity may be effected by any method including anti-sense therapy, gene therapy, and pharmaceutical intervention.
    Type: Application
    Filed: August 2, 2001
    Publication date: August 14, 2003
    Inventors: Zohar Yakhini, Michael Bittner, Jeff Trent, Amir Ben-Dor, Paul Meltzer, Yidong Chen, Ashani Weeraratna, Yuan Jiang, Nick Sampas, Edward Dougherty